/ Blog · Section 115BAA / 115BAB · Updated 2026-10-12
Section 115BAA (22%) & 115BAB (15%), when to opt in.
Taxation Laws (Amendment) Act 2019 introduced two concessional corporate tax regimes for Indian companies: Section 115BAA (22% + surcharge + cess for any domestic company) and Section 115BAB (15% + surcharge + cess for new manufacturing companies). Choice is one-time and IRREVOCABLE. For most Indian corporate taxpayers in 2026, 115BAA is the default winning choice. For specific manufacturing companies, 115BAB can save 7 percentage points. Here's the practitioner's decision framework.
Written by CA Durgesh Chavda
Chartered Accountant (ICAI) · Founder, Bharat Quantum Prospera · US incorporation, India-US DTAA, FEMA ODI, NRI taxation, cross-border structuring · LinkedIn
/ The three corporate tax regimes
What applies when.
Three regimes for Indian domestic companies as of FY 2025-26:
1. Standard regime:
- Rate: 25% (if turnover up to INR 400 crore in FY preceding by 2) or 30% (above).
- Full access to all deductions, carry-forward losses, Section 80 benefits.
- MAT applies at 15%.
2. Section 115BAA (concessional for any domestic company):
- Rate: 22% + 10% surcharge + 4% cess = effective ~25.17%.
- No MAT applies.
- Specific deductions FORFEITED (see below).
- One-time election by filing Form 10-IC on or before due date for ITR of the FY of election. Irrevocable.
3. Section 115BAB (concessional for NEW manufacturing company):
- Rate: 15% + 10% surcharge + 4% cess = effective ~17.16%.
- No MAT.
- Available only for new manufacturing companies incorporated on or after 1 October 2019 and commencing production on or before 31 March 2024 (deadline extended for specific sectors).
- Form 10-ID election. Irrevocable.
/ Section 115BAA conditions + what you lose
The trade-off.
To opt into Section 115BAA, the company must NOT claim:
- Section 10AA (SEZ unit deduction).
- Section 32(1)(iia) (additional depreciation 20% in year 1).
- Section 32AD (investment allowance).
- Section 33AB (Tea/Coffee/Rubber Development Account).
- Section 33ABA (Site Restoration Fund).
- Section 35(1)(ii) / (iia) / (iii) (donations for scientific research).
- Section 35(2AA) / (2AB) (approved research deduction).
- Section 35AD (investment-linked deduction).
- Section 35CCC / 35CCD (agricultural extension / skill dev projects).
- Chapter VI-A deductions except Section 80JJAA (new employment) and Section 80M (inter-corporate dividend).
- Carry-forward of losses related to the forfeited deductions.
For most companies (that are NOT SEZ-based, not heavy on scientific research, not operating in specified sectors), the forfeited deductions are minimal. Section 115BAA's 22% beats the standard 25%/30% in nearly every case for non-specialist companies.
/ Section 115BAB conditions
New manufacturing only.
Section 115BAB applies only if the company meets ALL conditions:
- Set up and registered on or after 1 October 2019.
- Commences manufacturing or production on or before 31 March 2024 (date extended for specific sectors; verify current state).
- Not formed by splitting up or reconstruction of an existing business.
- Does not use plant and machinery previously used in India (second-hand > 20% threshold triggers disqualification).
- Does not use building previously used as a hotel or convention centre.
- Engaged in manufacturing or production of article or thing. NOT engaged in: generating electricity (specific exception), mining, software development (controversial, see 2022 clarifications), book printing, re-labelling / packing.
- Same forfeited-deductions list as 115BAA plus more restrictive.
Transfer pricing with related parties: any related-party transaction at non-arm's-length pricing can trigger disqualification of 115BAB election.
/ Decision framework
Which regime wins.
For most domestic companies: Section 115BAA (22%) is the default best choice. The forfeited deductions are not meaningful for most businesses; the 3-8 percentage-point saving vs 25%/30% is real.
Exception - stay on standard regime if:
- You have significant SEZ Section 10AA deduction (reduces to zero under 115BAA).
- You have large carry-forward losses from prior years that would be forfeited.
- You have substantial Section 35 scientific research deductions.
- You are a research-driven pharma / biotech company with Section 35(2AB) in-house R&D deduction.
Opt into Section 115BAB if:
- You are a new manufacturing company (post-Oct-2019 incorporation).
- You will commence production by the deadline.
- You are confident of meeting all substantive conditions (not reconstruction, no prior plant & machinery, pure manufacturing).
Irrevocable election: once opted into 115BAA or 115BAB, cannot revert to standard regime. Think carefully.
Last updated: 2026-10-12.
/ Ready when you are
Private limited company - 22% or 25%? Decision is irrevocable.
Standard engagement: compare current year + 5-year projection under all three regimes with your actual deduction profile. Form 10-IC election by due date of ITR. Most companies win on Section 115BAA; verify yours.
FAQ
Common questions, answered.
Related reading